... in additional milestone payments. Crofelemer was being studied to treat chronic diarrhea for people who have HIV/AIDS. Napo said that an estimated 40 percent of HIV/AIDS patients in the United States suffer from diarrhea. Besides HIV-associated ...
http://ift.tt/1cN02mh
http://ift.tt/1cN02mh
No comments:
Post a Comment